SCHEDULE: Progyny, Inc. Schedule 13G Filing Update

Progyny, Inc. files an amendment to its Schedule 13G, reporting zero shares beneficially owned by Kleiner Perkins entities as of March 31, 2025.

Summary

• This filing is an amendment to Schedule 13G for Progyny, Inc. concerning its Common Stock.
• The reporting persons, KLEINER PERKINS CAUFIELD & BYERS XIII, LLC and KPCB XIII ASSOCIATES, LLC, have filed this amendment.
• As of March 31, 2025, both reporting persons have reported 0.00 shares beneficially owned.
• This represents 0% of the class of securities.
• The filing indicates no sole or shared voting power, and no sole or shared dispositive power for either reporting person.
• An agreement of joint filing is on file with the appropriate agencies.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the complete divestment indicated by the reporting persons, which could be interpreted as a lack of confidence or a strategic shift away from Progyny, Inc.

Negatives

• Kleiner Perkins entities, the reporting persons, have declared they beneficially own zero shares of Progyny, Inc. common stock as of the reporting date.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are typically made by institutional investors who beneficially own more than 5% of a company's voting stock. A filing reporting zero ownership by previously significant holders can signal a complete divestment or a change in reporting strategy.

Stakeholder Impact

• Shareholders may interpret the complete divestment by Kleiner Perkins entities as a signal of reduced institutional support or a negative outlook on the company's future performance.

Key Dates

Recommendation

The filing itself is a procedural update indicating a complete divestment by Kleiner Perkins entities, reporting zero beneficial ownership. While this could be a negative signal, it does not provide new operational or financial information about Progyny, Inc. itself. Therefore, a 'hold' recommendation is appropriate, pending further analysis of Progyny's core business performance and other market factors.

Keywords

Schedule 13G, Progyny, Inc., Kleiner Perkins, Beneficial Ownership, SEC Filing, Amendment, Common Stock